InsilicAll integrated Artificial Intelligence (A.I) and Big Data to create the first Drug Discovery platform in Latin America, optimizing research and development processes by reducing time, costs, and the need for animal testing.
BUSINESS MODEL: B2B (Software as a Service – Saas) for R&D in the pharmaceutical, cosmetics, and agribusiness industries
PRODUCT: In development
For further information, please contact us.
Back to Investors page